emodin has been researched along with Experimental Mammary Neoplasms in 2 studies
Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, L | 1 |
Lau, YK | 1 |
Xia, W | 1 |
Hortobagyi, GN | 1 |
Hung, MC | 1 |
Morita, H | 1 |
Umeda, M | 1 |
Masuda, T | 1 |
Ueno, Y | 1 |
2 other studies available for emodin and Experimental Mammary Neoplasms
Article | Year |
---|---|
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Division; Disease Models, An | 1999 |
Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FM3A cells.
Topics: Animals; Anthraquinones; Cell Survival; Emodin; Female; Mammary Neoplasms, Experimental; Mice; Mice, | 1988 |